Probability of long-term glioblastoma survival assessed

Probability of long-Term  glioblastoma survival assessed

(HealthDay) -- Although the overall mortality rate of glioblastoma is high, compared with patients newly diagnosed with glioblastoma, those who survive two years or more after diagnosis have a favorable conditional probability of future survival, according to a study published online May 8 in Cancer.

To investigate the conditional probability of survival, Derek R. Johnson, M.D., of the Mayo Clinic in Rochester, Minn., and colleagues conducted a population-based analysis using , , and End Results data from 10,022 patients diagnosed with glioblastoma between 1998 and 2008 who had been treated with radiation-containing regimens.

The researchers found that median survival for the cohort was 12.61 months. At diagnosis, the conditional probability of surviving an additional two years was 19.8 percent and this increased to 65.9 percent at five years after diagnosis. Compared with patients diagnosed in 1998 to 2004, an increased proportion of patients diagnosed in 2005 to 2008 survived 12 months from diagnosis and from six, 12, and 18 months after diagnosis. Age was the only factor associated with a higher risk of death at diagnosis and at one and three years following diagnosis.

"Patients surviving past two years from diagnosis have a relatively favorable conditional probability of survival into the future compared to newly diagnosed patients," the authors write. "This effect becomes more pronounced with increasing time since . These data will assist in the counseling of glioblastoma survivors."

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Recommended for you

Experts set strategic priorities for lymphoma research

date 5 hours ago

A committee of lymphoma experts today unveiled a strategic roadmap identifying key priority areas in both infrastructure and research that will be critical for advancing treatments for people with lymphoma. The report is meant to inform future research directions as well as fund ...

Research aims to reduce health care disparities

date 5 hours ago

The lesbian, gay, bisexual, transgender/transsexual, queer/questioning and intersex (LGBTQI) population has been largely understudied by the medical community. Researchers at Moffitt Cancer Center found that the LGBTQI community ...

Promising drug target identified in medulloblastoma

date 6 hours ago

Scientists at Dana-Farber/Boston Children's Cancer and Blood Disorders Center have identified a protein critical to both the normal development of the brain and, in many cases, the development of medulloblastoma, a fast-growing ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.